1-4 of 4
Ang Zhang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and preliminary efficacy of a novel loop-optimized, BCMA/CD19 bispecific CAR-T therapy for refractory or relapsed autoimmune diseases patients

Free
Jing PAN, SiYu Liu, Ang Zhang, Sha Li, Zelin Wang, ShengNan Zhou, ZhuoJun Ling
Journal: Blood
Blood (2025) 146 (Supplement 1): 2370.
https://doi.org/10.1182/blood-2025-2370
Published: 2025
Journal Articles

Enhanced efficacy and safety of optimized tandem CD19/CD20 CAR T-cell Therapy in refractory/relapsed B-cell lymphoma

Free
Jiaqi Guo, Ang Zhang, Weiwei Tian, Xiaoxi Zhou, Xiao Zhao, Yang Cao, Shaolong He, Jie Zhao, Lihong Liu, Lifang Huang, Yicheng Zhang, Bing Liu, Jia Wei
Journal: Blood
Blood (2025) 146 (Supplement 1): 2325.
https://doi.org/10.1182/blood-2025-2325
Published: 2025
Journal Articles

Novel bispecific epitope anti-CD5 nanobody CAR-T cells for refractory or relapsed T-cell malignancies

Free
Haiyang LU, Su LI, Ang Zhang, Chuanhe Jiang, Jing PAN, Xiaoxia Hu
Journal: Blood
Blood (2025) 146 (Supplement 1): 5933.
https://doi.org/10.1182/blood-2025-5933
Published: 2025
Journal Articles

Tandem CD19/20 CAR-T Showed Durable Efficacy in Patients with Relapsed/Refractory B-Cell Lymphoma: Interim Results from a Multicenter Phase I/II Trial

Free
Jia Wei, Xiaoxi Zhou, Hui Luo, Yang Cao, Jiaqi Guo, Jie Zhao, Lifang Huang, Ang Zhang, Lihong Liu, Weiwei Tian, Yicheng Zhang
Journal: Blood
Blood (2024) 144 (Supplement 1): 3132.
https://doi.org/10.1182/blood-2024-205207
Published: 2024